share_log

Illumina | 8-K: Current report

Illumina | 8-K: Current report

Illumina | 8-K:重大事件
美股sec公告 ·  08/06 16:24
Moomoo AI 已提取核心信息
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, reported its financial results for the second quarter ended June 30, 2024. The company announced a decrease in Core Illumina revenue by 6% from Q2 2023, with a reported revenue of $1.09 billion for Q2 2024. Despite the revenue decline, the company achieved a GAAP operating margin of 40.5% and a non-GAAP operating margin of 22.2% for the quarter. GAAP diluted earnings per share were $0.41, while non-GAAP diluted earnings per share stood at $1.09. Illumina also revised its fiscal year 2024 revenue guidance, expecting a decline of 2% to 3% from 2023, but raised its non-GAAP operating margin guidance to a range of 20.5% to 21%. Additionally, the company introduced guidance for Core Illumina non-GAAP diluted earnings per share in the...Show More
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, reported its financial results for the second quarter ended June 30, 2024. The company announced a decrease in Core Illumina revenue by 6% from Q2 2023, with a reported revenue of $1.09 billion for Q2 2024. Despite the revenue decline, the company achieved a GAAP operating margin of 40.5% and a non-GAAP operating margin of 22.2% for the quarter. GAAP diluted earnings per share were $0.41, while non-GAAP diluted earnings per share stood at $1.09. Illumina also revised its fiscal year 2024 revenue guidance, expecting a decline of 2% to 3% from 2023, but raised its non-GAAP operating margin guidance to a range of 20.5% to 21%. Additionally, the company introduced guidance for Core Illumina non-GAAP diluted earnings per share in the range of $3.80 to $3.95 for fiscal year 2024. A significant event during the quarter was the completion of the spin-off of GRAIL into a new public company on June 24, 2024. The financial results include the consolidated financial results for GRAIL up to the spin-off date. Illumina's CEO, Jacob Thaysen, acknowledged the constrained funding environment's impact on instrument demand but expressed confidence in the company's strategic priorities and operating excellence initiatives.
全球DNA测序和基于芯片技术领导者Illumina, Inc.公布了截至2024年6月30日第二季度的财务业绩。公司公布,核心Illumina收入较2023年第二季度下降6%,2024年第二季度报告的营业收入为10.9亿美元。尽管收入下降,该公司第二季度实现了40.5%的GAAP营业利润率和22.2%的非GAAP营业利润率。GAAP摊薄每股收益为0.41美元,而非GAAP摊薄每股收益为1.09美元。Illumina还修订了其2024财年营收指导,预计较2023年下降2%至3%,但将其非GAAP营业利润率指导提高至20.5%至21%的区间。此外,该公司针对2024财年的核心Illumina非GA...展开全部
全球DNA测序和基于芯片技术领导者Illumina, Inc.公布了截至2024年6月30日第二季度的财务业绩。公司公布,核心Illumina收入较2023年第二季度下降6%,2024年第二季度报告的营业收入为10.9亿美元。尽管收入下降,该公司第二季度实现了40.5%的GAAP营业利润率和22.2%的非GAAP营业利润率。GAAP摊薄每股收益为0.41美元,而非GAAP摊薄每股收益为1.09美元。Illumina还修订了其2024财年营收指导,预计较2023年下降2%至3%,但将其非GAAP营业利润率指导提高至20.5%至21%的区间。此外,该公司针对2024财年的核心Illumina非GAAP摊薄每股收益提供了3.80至3.95美元的指导。季度内的重要事件是GRAIL于2024年6月24日完成分拆并成为一家新的上市公司,财务业绩包括分拆日期前GRAIL的合并财务业绩。Illumina的首席执行官Jacob Thaysen认识到资金环境的不利影响了仪器需求,但对公司的战略重点和营运卓越计划表示信恳智能。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息